Chigasaki, Japan

Konomi Iguchi

This inventor holds 1 USPTO granted patent. Top assignee: Mercian Corporation. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Konomi Iguchi. Retrieved from https://idiyas.com/inventor/konomi-iguchi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Konomi Iguchi: Innovator in Pharmaceutical Purification

Introduction

Konomi Iguchi is a notable inventor based in Chigasaki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the purification of daunomycin. His innovative methods have the potential to enhance the efficiency of drug purification processes.

Latest Patents

Konomi Iguchi holds a patent for a method of purifying daunomycin. This invention involves eluting daunomycin from a hydrophobic porous synthetic resin carrier, which has adsorbed daunomycin from crude sources. The process utilizes a buffered aqueous solution containing a water-miscible organic solvent to recover purified daunomycin. This method allows for the efficient purification of daunomycin, also known as daunorubicin.

Career Highlights

Iguchi is associated with Mercian Corporation, where he applies his expertise in pharmaceutical innovations. His work focuses on improving drug purification techniques, which are crucial for the development of effective medical treatments.

Collaborations

Konomi Iguchi collaborates with esteemed colleagues such as Osamu Johdo and Takeo Yoshioka. Their combined efforts contribute to advancements in pharmaceutical research and development.

Conclusion

Konomi Iguchi's contributions to the field of pharmaceutical purification exemplify the importance of innovation in medicine. His patented method for purifying daunomycin showcases his commitment to enhancing drug efficacy and safety.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…